EnzymeBioSystems Deferred Tax Assets, Valuation Allowance
EnzymeBioSystems had Deferred Tax Assets, Valuation Allowance of $300.22 thousand as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2018-05-08
- 2018-03-31: Deferred Tax Assets, Valuation Allowance $300.22K.
- 2017-12-31: Deferred Tax Assets, Valuation Allowance $293.14K.
- 2017-06-30: Deferred Tax Assets, Valuation Allowance $427.82K.
- 2016-06-30: Deferred Tax Assets, Valuation Allowance $394.30K.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2018-03-31 | $300.22K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $293.14K 10-Q · filed 2018-02-21 |
| 2017-06-30 | $427.82K 10-Q · filed 2018-05-08 |
| 2016-06-30 | $394.30K 10-K · filed 2017-10-13 |